Funding Support CenterDF/HCC Sponsored FundingBridge ProjectThe Koch Institute (KI)-Dana-Farber/Harvard Cancer Center (DF/HCC) Bridge Project is designed to help bring the expertise of these two Centers to bear on complex translational problems in cancer research. A particular emphasis is placed on fostering joint approaches by engineers and cancer scientists, both basic and clinical/translational. This is a call for applications for collaborative research projects that focus on critical problems in glioblastoma and pancreatic cancer. Additional information on the Bridge Project including faculty presentations on unmet clinical needs and technology can be found at: https://wikis.mit.edu/confluence/display/BRIDGEPROJECT/ A. David Mazzone Research Awards ProgramThe A. David Mazzone Research Awards Program will fund a series of collaborative and innovative cancer research, career development, community outreach, and training projects to address a range of needs in prostate cancer and Lupron-treatable diseases. Funding Agency: The funding agency for the Program is a grant from the U.S. District Court for the District of Massachusetts of a pool of unclaimed funds from the 2004 class action suit settlement by TAP Pharmaceuticals. The class action suit was related to marketing and sales practices for the prostate cancer drug Lupron. The program is administered jointly through DF/HCC and the Prostate Cancer Foundation. Disparities in Cancer: Faculty Diversity Funding ProgramNew Faculty Recruitment: DF/HCC provides partial funding for the recruitment of new faculty (must be eligible for DF/HCC membership) from under-represented racial/ethnic or disadvantaged backgrounds (URM) to a DF/HCC member institution. Nodal AwardsDF/HCC requests proposals for pilot projects that enhance or create new “nodal point” interactions between disease- and discipline-based programs. Proposals for projects that further enhance the research in the area of eliminating cancer disparities will also be considered. Protocol Specific Research Support Protocol Specific Research Support (PSRS) funds provide support for important unfunded or under-funded, investigator-initiated, early phase trials, with a focus on facilitating the translation of new treatment or biomarker concepts from laboratory to clinic. Applications are reviewed by the DF/HCC Scientific Resource and Prioritization Committee. For more information, please contact Dr. Jeffrey Clark at (617) 643-3415. UMass Boston-DF/HCC U54 Partnership Grant |
||